证券代码：002795 证券简称：永和智控 公告编号：2025-068 永和流体智控股份有限公司 关于公开挂牌转让普乐新能源科技（泰兴）有限公司51%股权 及债权的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 永和流体智控股份有限公司（以下简称"公司"）于 2025 年 10 月 10 日、2025 年 10 月 29 日召开第五届董事会第二十二次临时会议、第五届监事会第十七次临时会议 及 2025 年第二次临时股东大会，审议通过了《关于拟公开挂牌转让普乐新能源科技 （泰兴）有限公司 51%股权及债权的议案》，同意公司在产权交易所公开挂牌转让 控股子公司普乐新能源科技（泰兴）有限公司（以下简称"泰兴普乐"）51%股权及公 司对泰兴普乐的全部债权，并同意授权公司董事长或董事长授权的代理人负责具体实 施 该 事 项 。 具 体 内 容 详 见 公 司 于 2025 年 10 月 14 日 在 巨 潮 资 讯 网 （http://www.cninfo.com.cn）、《证券时报》和《证券日报》刊登的《关于拟公开挂 牌转让普乐新能源科技（泰兴 ...

得润电子：聘任邱扬担任公司总裁 11月28日，得润电子（002055）发布公告称，公司总裁刘标因个人原因辞去总裁职务，仍继续担任公司 董事、副董事长等职。董事会同日聘任邱扬为新任总裁，任期至第八届董事会届满。 资料显示，得润电子成立于1992年4月，主营业务是电子连接器和精密组件的研发、生产及销售。 所属行业：电子–消费电子–消费电子零部件及组装 中远通：拟投资500万元设立香港子公司 11月28日，中远通（301516）发布公告称，公司拟使用自有资金500万元在香港特别行政区投资设立全 资子公司（简称"香港子公司"）。 同日公告，公司拟在西安投资设立分公司暨西安研究院，主要为了增强研发技术实力，助力公司开发新 产品、拓展新市场。 资料显示，中远通成立于1999年8月，主营业务是各类电源产品的研发、生产和销售业务。 所属行业：电力设备–其他电源设备Ⅱ–其他电源设备Ⅲ 一汽解放：联合宁德时代、特来电增资解放时代合计注资4.12亿元 11月28日，一汽解放（000800）发布公告称，公司拟通过全资子公司解放有限向合营企业解放时代新能 源科技有限公司现金增资1.91亿元。同步参与本次增资的还有现有股东宁德时代及新引 ...

Group 1 - The core point of the news is that major shareholders of Yonghe Intelligent Control plan to reduce their holdings of the company's shares within a specified timeframe, which may impact the stock price and investor sentiment [1] Group 2 - Mr. Xia Zuwang, a shareholder holding over 5% of Yonghe Intelligent Control, plans to reduce his holdings by up to approximately 13.37 million shares (not exceeding 3% of total share capital) from December 22, 2025, to March 21, 2026 [1] - Ms. Tan Mengwen, a director and senior executive holding 196,000 shares (0.44% of total share capital), intends to reduce her holdings by up to 490,000 shares (not exceeding 0.11% of total share capital) during the same period [1] - Ms. Liao Lina, another senior executive holding approximately 3.14 million shares (0.7% of total share capital), plans to reduce her holdings by up to approximately 780,000 shares (not exceeding 0.18% of total share capital) in the same timeframe [1] Group 3 - For the first half of 2025, Yonghe Intelligent Control's revenue composition is as follows: Industrial sector accounts for 89.41%, Medical services and others account for 10.57%, and Photovoltaic battery cells account for 0.02% [1] - The current market capitalization of Yonghe Intelligent Control is 2.8 billion yuan [2]

证券代码：002795 证券简称：永和智控 公告编号：2025-067 永和流体智控股份有限公司 关于持股 5%以上股东、部分董事及高级管理人员减持股份 预披露公告 公司持股5%以上股东夏祖望先生、公司董事、副总经理谭梦雯女士、公 司财务总监廖丽娜女士保证向本公司提供的信息内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示： 1、持有永和流体智控股份有限公司（以下简称"公司"或"本公司"）5%以上 股东夏祖望先生计划自本减持计划公告披露之日起15个交易日后的3个月内（即 2025 年 12 月 22 日至 2026 年 3 月 21 日）通过集中竞价和大宗交易方式（根据 相关法律法规规定禁止减持的期间除外）减持本公司股份合计不超过 13,372,600 股（占本公司总股本的比例不超过 3.00%）。 2、持有公司股份 1,960,000 股（占本公司总股本比例 0.44%）的董事、高级 管理人员谭梦雯女士自本减持计划公告披露之日起15个交易日后的3个月内（即 2025 年 12 月 22 日至 2026 年 3 月 21 ...

永和智控（002795）(002795.SZ)发布公告，公司于近日收到股东夏祖望先生、公司董事、副总经理谭 梦雯女士、公司财务总监廖丽娜女士出具的《关于股份减持计划的告知函》，以上股东拟合计减持公司 不超3.29%股份。 ...

Summary of Key Points Core Viewpoint - On November 27, several A-share listed companies disclosed their shareholding changes, with notable increases in holdings from some companies and reductions from others, indicating varying levels of confidence among stakeholders in the market [1]. Group 1: Shareholding Increases - Mindray Medical's actual controller and chairman, Li Xiting, plans to increase his stake in the company by 200 million yuan [2]. - Everbright Bank saw Citic Financial Assets increase its holdings in both A-shares and H-shares by a total of 1% from July 24 to November 27 [2]. - MaiDe Medical's chairman and actual controller, Lin Junhua, proposed a share buyback plan ranging from 20 million to 40 million yuan [2]. Group 2: Shareholding Reductions - Yonghe Intelligent Control's shareholders plan to collectively reduce their holdings by no more than 3.29% [2]. - Perfect World’s actual controller, Chi Yufeng, intends to reduce his stake by no more than 1.70% [2]. - XueNeng Technology's shareholder, Shanghang Xingyuan, plans to reduce holdings by no more than 1.6816% [2]. - Hongxiang New Materials' controlling shareholder, Hongbo Chemical, has cumulatively reduced its stake by 3% recently [2]. - Nearshore Protein's shareholders plan to collectively reduce their holdings by no more than 0.1997% [2]. - Aerospace Hongtu's director and executive, Huang Yongbo, plans to reduce his stake by no more than 0.0019% [2]. - Yidelong's shareholder, Wang Ming, intends to reduce his holdings by no more than 2% [2]. - Zhongman Petroleum's shareholders plan to collectively reduce their holdings by no more than 3% [2]. - Innovation New Materials' shareholder, Hualian Group, plans to reduce its stake by no more than 1% [2]. - Saiwei Electronics has seen the National Integrated Circuit Industry Investment Fund reduce its holdings by 6.4278 million shares [2]. - Zhongzhi Technology's shareholder, Zhongzhi Investment, plans to reduce its stake by no more than 0.76% [2]. - Jiangsu Boyun's shareholder, Lansan Venture Capital, intends to reduce its holdings by no more than 1% [2]. - Huasheng Lithium's deputy general manager, Zhang Conghe, plans to reduce his stake by no more than 0.31% [2]. - Huasheng Electric's shareholder, Dunxing Jucai, reduced its holdings by 444,500 shares between November 25 and 27 [2]. - Matrix Technology's shareholder, Li Jun, plans to reduce his stake by no more than 0.22% [2].

永和智控公告称，持股5%以上股东夏祖望、董事兼副总经理谭梦雯、财务总监廖丽娜因个人资金需 要，拟减持股份。夏祖望拟自2025年12月22日至2026年3月21日，通过集中竞价和大宗交易方式减持不 超1337.26万股，占总股本不超3%；谭梦雯拟通过集中竞价减持不超49万股，占比不超0.11%；廖丽娜 拟通过集中竞价减持不超78.4万股，占比不超0.18%。本次减持计划实施存在不确定性。 ...

Core Viewpoint - Yonghe Intelligent Control Co., Ltd. is divesting all its investments in private oncology hospitals, marking a complete exit from the healthcare sector due to ongoing financial struggles and poor performance of its medical assets [2][3][5]. Group 1: Divestment Details - Yonghe Intelligent Control has initiated the public transfer of 100% equity in its wholly-owned subsidiary, Kunming Medical Oncology Hospital, with a starting price of no less than 35.93 million yuan [3][4]. - This divestment is part of a broader strategy, as Yonghe has already attempted to sell its stakes in three other oncology hospitals since 2020, including Dazhou Medical Oncology Hospital, Liangshan High-tech Oncology Hospital, and Xi'an Medical Oncology Hospital [3][4]. - The financial performance of Kunming Medical has been poor, with revenues of 11.58 million yuan and a net loss of 6.59 million yuan for the first seven months of 2025, contributing to Yonghe's decision to sell [3][6]. Group 2: Financial Performance - Yonghe Intelligent Control's main business includes fluid control products, oncology precision radiation treatment, and photovoltaic battery production. The company reported a revenue of 1.01 billion yuan in 2021, marking a 55.71% increase [5]. - However, the company's financial situation deteriorated significantly from 2022 to 2024, with revenues declining from 990 million yuan in 2022 to 823 million yuan in 2024, and net losses increasing from 26.19 million yuan to 297 million yuan during the same period [6]. - The decline in performance is attributed to reduced income from the valve and fitting business, lower product gross margins, and high depreciation and labor costs [6][7]. Group 3: Strategic Shift - Following the divestment of its medical assets, Yonghe Intelligent Control is expected to refocus on its core business operations. The company has not yet communicated its future strategic direction or potential new growth areas [7].

11月25日，永和智控盘中上涨2.10%，截至10:44，报6.32元/股，成交1.40亿元，换手率5.19%，总市值 28.17亿元。 截至9月30日，永和智控股东户数3.13万，较上期增加54.10%；人均流通股13876股，较上期减少 35.11%。2025年1月-9月，永和智控实现营业收入5.82亿元，同比减少7.25%；归母净利润-6046.25万 元，同比增长20.65%。 分红方面，永和智控A股上市后累计派现2.00亿元。近三年，累计派现0.00元。 资金流向方面，主力资金净流出60.33万元，特大单买入849.07万元，占比6.06%，卖出1052.84万元，占 比7.52%；大单买入2730.03万元，占比19.50%，卖出2586.60万元，占比18.47%。 责任编辑：小浪快报 资料显示，永和流体智控股份有限公司位于浙江省台州市玉环市清港镇工业产业集聚区，成立日期2003 年8月28日，上市日期2016年4月28日，公司主营业务涉及医疗健康产业、流体智控业务。主营业务收入 构成为：阀门管件类89.41%，医疗服务及其他产业10.57%，光伏电池片0.02%。 永和智控所属申万行业为：机械 ...

证券日报网讯 11月24日晚间，永和智控发布公告称，公司于2025年11月18日召开第五届董事会第二十 六次临时会议、第五届监事会第二十次临时会议，审议通过了《关于拟公开挂牌转让昆明医科肿瘤医院 有限公司100%股权的议案》，同意公司在产权交易所公开挂牌转让全资孙公司昆明医科肿瘤医院有限 公司（简称"昆明医科"）100%股权，并同意授权公司董事长或董事长授权的代理人负责具体实施该事 项。截至本公告披露日，公司已向西南联合产权交易所（以下简称"西南联交所"）提交《信息披露申请 书》并获受理，西南联交所对外发布了正式信息披露公告，昆明医科100%股权首次挂牌价格为人民币 3，592.77万元，首次挂牌公告起止日期为2025年11月24日至2025年12月5日。 （文章来源：证券日报） ...